In conclusion, it is important to recognize the association between
COVID-19 and acute pulmonary embolism (PE), and to incorporate clinical
and laboratory findings, as well as non-enhanced chest CT features
when available, into the decision-making process regarding the use of
CTPA scans in patients with confirmed SARS-CoV-2 infection.